In preclinical studies, topical CUR61414 reduced Hh signaling and shrank BCCs in mice, but this study found no clinical efficacy in human superficial or nodular BCCs.
1 citations
,
March 2013 in “Revista de Investigaciones Veterinarias del Perú” This study found that a single application of 0.1% aqueous benzalkonium chloride solution effectively treated dermatomycosis caused by Trichophyton species in guinea pigs.
July 2024 in “Health Science Reports” In this retrospective study, remdesivir was administered on an outpatient basis to Covid-19 patients, showing effectiveness with low side effects. Early administration improved outcomes, corticosteroids had limited benefits, and body mass index did not significantly impact hospitalization rates.
3 citations
,
May 2025 in “Frontiers in Pharmacology” This study identified known and potential novel adverse events, such as squamous cell carcinoma and dehydration, for vismodegib, underlining the importance of monitoring especially in the first two months of treatment.
May 2026 in “Southeast Asian Journal of Case Report and Review” In this study, individualized homoeopathic treatment with Silicea showed a marked reduction in depigmentation for a case of vitiligo, with a likely causal link suggested by evaluation criteria.
12 citations
,
April 2005 in “Mycoses” This study found that 1-day itraconazole therapy was more effective for acute vulvovaginal candidosis than for recurrent cases, where relapses occurred despite no yeast resistance.
17 citations
,
March 1994 in “Pediatric Dermatology” This report describes the co-occurrence of vitiligo and alopecia areata in pediatric cases but provides no new clinical findings.
4 citations
,
August 2024 in “Journal of Clinical Medicine” This study reported an increased likelihood of hidradenitis suppurativa flares in patients who received mRNA COVID-19 vaccines compared to those who received non-mRNA vaccines, indicating a potential association that warrants further research in larger populations.
4 citations
,
January 1989
July 2022 in “International Journal of Research in Dermatology” This report details a pediatric COVID-19 case with skin symptoms aligning with multisystem inflammatory syndrome.
1 citations
,
November 2023 in “Acta Dermato Venereologica” 6 citations
,
July 2021 in “Bulletin of the National Research Centre/Bulletin of the National Research Center” This review discusses the transmission and immune response of SARS-CoV-2 and highlights ongoing research for developing vaccines and antiviral treatments, but it presents no new clinical findings.
32 citations
,
July 2003 in “Annals of the Rheumatic Diseases” This case report describes the successful treatment of a 13-year-old girl's autoimmune symptoms with co-trimoxazole, an antibiotic with immunomodulatory properties.
11 citations
,
December 2020 in “Journal of Drugs in Dermatology” This study reported that COVID-19 skin manifestations, such as exanthema and chilblains, varied in timing but resolved positively with proper treatment.
This ongoing study is evaluating whether Ayurvedic treatments, specifically Panchagavya Ghrita combined with Amalakyadi Kashaya, can improve the quality of life for cancer patients experiencing side effects from chemotherapy and radiotherapy, compared to standard care, using a variety of quality-of-life and symptom severity scales.
January 2024 in “Clinical and Experimental Vaccine Research” In this report, the authors describe a case where a child developed alopecia areata after receiving the fifth dose of a rabies vaccine, suggesting that the vaccine may predispose to this autoimmune hair loss by affecting immune regulation.
119 citations
,
October 2011 in “Journal of Veterinary Internal Medicine” This review discusses the clinical manifestations and immune response to Rhodococcus equi infection in foals but reports no new clinical results.
April 2023 in “Journal of Investigative Dermatology” This study found that mRNA booster vaccinations for SARS-CoV-2 increased protective antibodies without worsening autoimmune disease activity in patients with pemphigus and bullous pemphigoid.
October 2022 in “Amplla Editora eBooks” The document's conclusion cannot be provided because the document is not accessible or understandable.
21 citations
,
August 2002 in “British Journal of Ophthalmology” This report notes that while surgical excision is typically curative for squamous cell carcinoma, the authors suggest considering the intralesional use of cidofovir for its potential success without systemic toxicity.
26 citations
,
January 2004 in “Journal of Toxicology Clinical Toxicology” This case report details a 43-year-old woman who survived severe multiorgan injury from accidental Colchicum autumnale poisoning, resulting in ongoing muscle weakness and intermittent hair loss three years after the incident.
October 2025 in “Dermatology Practical & Conceptual” In this study, researchers in India determined that 37.8% of patients experienced alopecia associated with COVID-19, particularly linked to disease severity, stressing the need for careful patient history review to guide treatment and reassurance.
March 2006 in “Drug Discovery Today: Therapeutic Strategies” The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.
1 citations
,
February 2009 in “Journal of The American Academy of Dermatology” Children's Serum Sickness-Like Reaction is often linked to antibiotics, especially amoxicillin, and involves symptoms like rash, fever, and joint issues.
40 citations
,
August 2010 in “Archives of dermatology” This case report describes the youngest known patient with viral-associated trichodysplasia of immunosuppression, where systemic valganciclovir therapy improved facial papule eruptions following cardiac transplantation.
January 2025 in “The Egyptian Journal of Hospital Medicine” This study observed significant repigmentation in localized stable vitiligo lesions treated with oral baricitinib, with even more improvement when combined with topical tacrolimus, and reported no side effects.
7 citations
,
June 2000 in “Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Māzandarān/Journal of Mazandaran University of Medical Sciences” In this study, older age and fewer hepatitis vaccinations were linked to lower HBV antibody responses in nursing staff, with antibody levels declining over five years, suggesting a potential need for booster doses.
13 citations
,
July 2019 in “Toxicology research” In this study, ethanamizuril was found to cause alopecia, biochemical changes, and organ damage at higher doses in rats, with a no-observed-adverse-effect level of 20 mg/kg over 30 days.
12 citations
,
October 2001 in “British Journal of Ophthalmology” This paper suggests intralesional cidofovir as a potentially effective treatment for SCC with no systemic toxicity observed, but surgical excision remains the standard for its curative outcomes and thorough evaluation.
13 citations
,
September 2022 in “International Journal of Molecular Sciences” This study identifies five compounds, including gemcitabine and methylene blue, that inhibit SADS-CoV and suggests their potential for developing antiviral drugs against future outbreaks.